Lymphokines and monokines in the clinic.
There has been a remarkable increase in understanding of the control of immune reactions and hemopoietic stem cell proliferation by cytokines. At a recent meeting(∗) investigators engaged in basic research, clinicians, and representatives of bioengineering and pharmaceutical companies gathered to discuss the present state and future potential of clinical application of natural and recombinant lymphokines and cytokines.